Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2022		133,236,687
Beginning balance at Dec. 31, 2022	$ 2,077,963	$ 13	$ 1,709,835	$ (9,122)	$ 377,237	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		517,168
Exercise of stock option (in shares)		177,102
Exercise of stock options	2,310		2,310
Stock-based compensation	25,481		25,481
Other comprehensive (loss) income	5,903			5,903
Contributions from noncontrolling interest owners	100					100
Net loss	(140,956)				(140,900)	(56)
Ending balance (in shares) at Mar. 31, 2023		133,930,957
Ending balance at Mar. 31, 2023	$ 1,970,801	$ 13	1,737,626	(3,219)	236,337	44
Beginning balance (in shares) at Dec. 31, 2023	134,781,286	134,781,286
Beginning balance at Dec. 31, 2023	$ 1,590,236	$ 13	1,828,862	(815)	(237,824)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		950,254
Vesting of restricted common stock	1	$ 1
Exercise of stock option (in shares)		112,020
Exercise of stock options	220		220
Stock-based compensation	23,757		23,757
Other comprehensive (loss) income	(1,582)			(1,582)
Net loss	$ (65,276)				(65,276)
Ending balance (in shares) at Mar. 31, 2024	135,843,560	135,843,560
Ending balance at Mar. 31, 2024	$ 1,547,356	$ 14	$ 1,852,839	$ (2,397)	$ (303,100)	$ 0